Risperidone

Jump to: navigation, search

Synonyms / Brand Names: Risperidona, Risperidonum, Risperdal, Risperdal Consta, Risperdal M-Tab, Risperidal M-Tab, Risperin, Rispolept, Rispolin, Sequinan

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Dosing and Administration

Schizophrenia

  • Usual initial dose: Risperidone can be administered on either a BID or a QD schedule. In early clinical trials, Risperidone was generally administered at 1 mg BID initially, with increases in increments of 1 mg BID on the second and third day, as tolerated, to a target dose of 3 mg BID by the third day. Subsequent controlled trials have indicated that total daily Risperidone doses of up to 8 mg on a QD regimen are also safe and effective. However, regardless of which regimen is employed, in some patients a slower titration may be medically appropriate. Further dosage adjustments, if indicated, should generally occur at intervals of not less than 1 week, since steady state for the active metabolite would not be achieved for approximately 1 week in the typical patient. When dosage adjustments are necessary, small dose increments/decrements of 1–2 mg are recommended.

Bipolar mania

  • Usual dose: Risperidone should be administered on a once daily schedule, starting with 2 mg to 3 mg per day. Dosage adjustments, if indicated, should occur at intervals of not less than 24 hours and in dosage increments/decrements of 1 mg per day, as studied in the short-term, placebo-controlled trials. In these trials, short-term (3 week) anti-manic efficacy was demonstrated in a flexible dosage range of 1–6 mg per day. Risperidone doses higher than 6 mg per day were not studied.


FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.

Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.

Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.

Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information

Trial Resources
Ongoing Trials, Trial Results

Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.

Media Resources
Slides, Video, Images, MP3, Podcasts, etc.

Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.

International Resources
en Español






FDA Package Insert Resources

Indications

Contraindications

Side Effects

Drug Interactions

Precautions

Overdose

Instructions for Administration

How Supplied

Pharmacokinetics and Molecular Data

FDA label

FDA on Risperidone

Return to top

Publication Resources

Most Recent Articles on Risperidone

Review Articles on Risperidone

Articles on Risperidone in N Eng J Med, Lancet, BMJ

WikiDoc State of the Art Review

Textbook Information on Risperidone

Return to top

Trial Resources

Ongoing Trials with Risperidone at Clinical Trials.gov

Trial Results with Risperidone

Return to top

Guidelines & Evidence Based Medicine Resources

US National Guidelines Clearinghouse on Risperidone

Cochrane Collaboration on Risperidone

Cost Effectiveness of Risperidone

Return to top

Media Resources

Powerpoint Slides on Risperidone

Images of Risperidone

Podcasts & MP3s on Risperidone

Videos on Risperidone

Return to top

Patient Resources

Patient Information from National Library of Medicine

Patient Resources on Risperidone

Discussion Groups on Risperidone

Patient Handouts on Risperidone

Blogs on Risperidone

Risperidone in the News

Risperidone in the Marketplace

Return to top

International Resources

Risperidone en Español

Return to top


The content of this page is taken from the FDA package insert for this drug and should not be edited.


Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added Pictures

Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs

Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link Here
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Linked-in.jpg
Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox